Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoid treatment for autism: a proof-of-concept randomized trial
Adi Aran, Moria Harel, Hanoch Cassuto, et al.
Molecular Autism (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 140

Showing 1-25 of 140 citing articles:

Autism Spectrum Disorder
Tomoya Hirota, Bryan H. King
JAMA (2023) Vol. 329, Iss. 2, pp. 157-157
Closed Access | Times Cited: 358
An Update on Psychopharmacological Treatment of Autism Spectrum Disorder
Ramkumar Aishworiya, Tatiana Valica, Randi J. Hagerman, et al.
Neurotherapeutics (2022) Vol. 19, Iss. 1, pp. 248-262
Open Access | Times Cited: 146
The Polypharmacological Effects of Cannabidiol
Jorge Iván Castillo-Arellano, Ana Canseco-Alba, Stephen J. Cutler, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3271-3271
Open Access | Times Cited: 73
Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis
Spyridon Siafis, Remzi Oğulcan Çıray, Hui Wu, et al.
Molecular Autism (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 71
Autism spectrum disorder: pathogenesis, biomarker, and intervention therapy
Hongbin Zhuang, Zhiyuan Liang, Guanwei Ma, et al.
MedComm (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 16
Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain
Barbara Stella, Francesca Baratta, Carlo Della Pepa, et al.
Drugs (2021) Vol. 81, Iss. 13, pp. 1513-1557
Open Access | Times Cited: 99
Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study
Micha Hacohen, Orit Stolar, Matitiahu Berkovitch, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 44
Novel treatments in autism spectrum disorder
Danielle Baribeau, Jacob Vorstman, Evdokia Anagnostou
Current Opinion in Psychiatry (2022) Vol. 35, Iss. 2, pp. 101-110
Closed Access | Times Cited: 38
Probiotics and Prebiotics in the Treatment of Autism Spectrum Disorder: A Narrative Review
Si Zhang, Fei Han, Qiong Wang, et al.
Journal of Integrative Neuroscience (2024) Vol. 23, Iss. 1, pp. 20-20
Open Access | Times Cited: 8
Cannabinoids in the Treatment of Selected Mental Illnesses: Practical Approach and Overview of the Literature
Kirsten Müller‐Vahl
Pharmacopsychiatry (2024) Vol. 57, Iss. 03, pp. 104-114
Open Access | Times Cited: 8
Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: Obligatory role of hippocampal GPR55 receptors
Antonia Manduca, Valeria Buzzelli, Alessandro Rava, et al.
Pharmacological Research (2024) Vol. 203, pp. 107176-107176
Open Access | Times Cited: 8
Can Memantine Treat Autism? Answers from Preclinical and Clinical Studies
Sawsan Aboul‐Fotouh, Sohir M Zohny, Esraa M. Elnahas, et al.
Neuroscience & Biobehavioral Reviews (2025) Vol. 169, pp. 106019-106019
Closed Access | Times Cited: 1
Therapeutic potential of cannabidiol polypharmacology in neuropsychiatric disorders
Olivier J. Manzoni, Antonia Manduca, Viviana Trezza
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 1
Delivering therapeutic cannabinoids via skin: Current state and future perspectives
Akeemat O. Tijani, Divya Thakur, Dhruv Mishra, et al.
Journal of Controlled Release (2021) Vol. 334, pp. 427-451
Closed Access | Times Cited: 53
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
João Francisco Cordeiro Pedrazzi, Frederico Rogério Ferreira, Danyelle Silva-Amaral, et al.
Psychopharmacology (2022) Vol. 239, Iss. 9, pp. 2713-2734
Closed Access | Times Cited: 31
A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ
Aviad Schnapp, Moria Harel, Dalit Cayam-Rand, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1685-1685
Open Access | Times Cited: 29
Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD)
Michelle Iffland, Nuala Livingstone, Mikaela Jorgensen, et al.
Cochrane library (2023) Vol. 2023, Iss. 10
Closed Access | Times Cited: 19
Medicinal Cannabis for Paediatric Developmental, Behavioural and Mental Health Disorders
Daryl Efron, Kaitlyn Taylor
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 8, pp. 5430-5430
Open Access | Times Cited: 18
A systematic review of cannabidiol trials in neurodevelopmental disorders
Nina-Francecsa Parrella, Aron T. Hill, Peter G. Enticott, et al.
Pharmacology Biochemistry and Behavior (2023) Vol. 230, pp. 173607-173607
Open Access | Times Cited: 18
Cannabinoid treatment for the symptoms of autism spectrum disorder
Adi Aran, Dalit Cayam Rand
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 1, pp. 65-79
Closed Access | Times Cited: 6
Cannabidiol is a behavioral modulator in BTBR mouse model of idiopathic autism
Sarah H. Shrader, Nicholas Mellen, Jun Cai, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 6
Endocannabinoid System Changes throughout Life: Implications and Therapeutic Potential for Autism, ADHD, and Alzheimer’s Disease
Kamila Gabrieli Dallabrida, Jeane Maria de Oliveira, Ellen Schavarski Chade, et al.
Brain Sciences (2024) Vol. 14, Iss. 6, pp. 592-592
Open Access | Times Cited: 6
Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis
Nir Treves, Noa Mor, Karel Allegaert, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 35
Cannabis for Medical Use: Analysis of Recent Clinical Trials in View of Current Legislation
Francesca Baratta, Irene Pignata, Lorenzo Ravetto Enri, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 26
Towards the convergent therapeutic potential of G protein‐coupled receptors in autism spectrum disorders
Anil Annamneedi, Caroline Gora, Ana Dudas, et al.
British Journal of Pharmacology (2023)
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top